Tramadol is used to treat moderate to moderately severe pain. It works by changing how your body senses and responds to pain.[2] Ultram is currently approved and in use across 38 indications[4].[1]
Ultram is one of 566 small molecule programs targeting Peritonsillar Abscess. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
143 competitors in Osteoarthritis
Ultram
Toradol
Cataflam
Bayer Aspirin
Enbrel
Glucophage
Precedex
Protonix
Catapres
MS Contin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Mar 3, 1995
ULTRAM
NDA NDA020281
May 5, 2005
RYBIX ODT
NDA NDA021693
Sep 8, 2005
ULTRAM ER
NDA NDA021692
Dec 30, 2008
RYZOLT
NDA NDA021745
May 7, 2010
CONZIP
NDA NDA022370
Sep 1, 2020
QDOLO
NDA NDA214044
Sources
Details